68 related articles for article (PubMed ID: 1300205)
1. The analysis of a multiple-dose, combination-drug clinical trial using response surface methodology.
Phillips JA; Cairns V; Koch GG
J Biopharm Stat; 1992; 2(1):49-67. PubMed ID: 1300205
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS
Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
[TBL] [Abstract][Full Text] [Related]
3. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
Papademetriou V; Hainer JW; Sugg J; Munzer D;
Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
[TBL] [Abstract][Full Text] [Related]
4. Fallback tests in dose-response clinical trials.
Dmitrienko A; Wiens B; Westfall P
J Biopharm Stat; 2006; 16(5):745-55. PubMed ID: 17037269
[TBL] [Abstract][Full Text] [Related]
5. Comparison of several testing strategies for combination drug efficacy trials based on the closure principle.
Soulakova JN
Stat Med; 2009 Jan; 28(2):260-73. PubMed ID: 18991315
[TBL] [Abstract][Full Text] [Related]
6. Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: the Ramipril-Hydrochlorothiazide Hypertension trial.
White WB; Cleveland JM; Rolleri RL;
J Hum Hypertens; 2008 Aug; 22(8):559-68. PubMed ID: 18463672
[TBL] [Abstract][Full Text] [Related]
7. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
[TBL] [Abstract][Full Text] [Related]
8. Global tests for combination drug studies in factorial trials.
Hung HM
Stat Med; 1996 Feb; 15(3):233-47. PubMed ID: 8643882
[TBL] [Abstract][Full Text] [Related]
9. Placebo controlled double-blind randomised cross-over trial of atenolol, hydrochlorothiazide and amiloride, and the combination (Kalten) in patients over 60 years of age.
Jackson G; Rowland M; Adam G; MacFarlane E; Jackson PG
Br J Clin Pract; 1986 Jun; 40(6):230-4. PubMed ID: 3527246
[No Abstract] [Full Text] [Related]
10. Application of response surface methodology and factorial designs to clinical trials for drug combination development.
Stewart WH
J Biopharm Stat; 1996 Jul; 6(3):219-30. PubMed ID: 8854227
[TBL] [Abstract][Full Text] [Related]
11. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
12. Beta-blocker/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial.
Sorof JM; Cargo P; Graepel J; Humphrey D; King E; Rolf C; Cunningham RJ
Pediatr Nephrol; 2002 May; 17(5):345-50. PubMed ID: 12042891
[TBL] [Abstract][Full Text] [Related]
13. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
Pool JL; Schmieder RE; Azizi M; Aldigier JC; Januszewicz A; Zidek W; Chiang Y; Satlin A
Am J Hypertens; 2007 Jan; 20(1):11-20. PubMed ID: 17198906
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
15. Dose-response curves in antihypertensive combination therapy: results of a controlled clinical trial.
Letzel H; Bluemner E
J Hypertens Suppl; 1990 Sep; 8(4):S83-6. PubMed ID: 2258790
[TBL] [Abstract][Full Text] [Related]
16. Comparison of treatments in a combination therapy trial.
Patel HI
J Biopharm Stat; 1991; 1(2):171-83. PubMed ID: 1844694
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hypertension by enalapril and hydrochlorothiazide separately and together: a multicenter study.
Rosenthal T; Grossman E; Rathaus M; Bernheim J; Zevin D; Levi J; Weinstein J; Rogel S
Isr J Med Sci; 1990 Feb; 26(2):63-6. PubMed ID: 2180849
[TBL] [Abstract][Full Text] [Related]
18. Large sample tests for binary outcomes in fixed-dose combination drug studies.
Wang SJ; Hung HM
Biometrics; 1997 Jun; 53(2):498-503. PubMed ID: 9192448
[TBL] [Abstract][Full Text] [Related]
19. [Double blind randomized comparative study of two antihypertensive combinations. Enalapril-hydrochlorothiazide versus enalapril-nifedipine in 240 hypertensive patients resistant to monotherapy].
Frances Y; Lafay V; Madona O; Chastang C; Souchet T; Chazelle F
Therapie; 1996; 51(1):35-9. PubMed ID: 8762218
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of hypertension. Cost conscious prevention of complications].
Kolloch RE
MMW Fortschr Med; 2003 Nov; 145(47):64. PubMed ID: 14725042
[No Abstract] [Full Text] [Related]
[Next] [New Search]
